Shared scheme for assessing drugs for multiple sclerosis: Why are eyes tightly shut to considering causes other than autoimmunity?

BMJ 2003; 326 doi: 10.1136/bmj.326.7400.1213 (Published 29 May 2003)
Cite this as: BMJ 2003;326:1213.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Access to the full text of this article requires a subscription or payment

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL